Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-24
2008-11-11
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000, C548S452000, C548S465000, C546S200000, C546S276700
Reexamination Certificate
active
07449447
ABSTRACT:
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1:useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
REFERENCES:
patent: 5712145 (1998-01-01), Houghton et al.
patent: 0 381 216 (1995-12-01), None
patent: WO 89/04669 (1989-06-01), None
patent: WO 98/14181 (1998-04-01), None
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/22496 (1998-05-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 01/77113 (2001-10-01), None
patent: WO 01/81325 (2001-11-01), None
patent: WO 02/08187 (2002-01-01), None
patent: WO 02/08198 (2002-01-01), None
patent: WO 02/08244 (2002-01-01), None
patent: WO 02/08251 (2002-01-01), None
patent: WO 02/08256 (2002-01-01), None
patent: WO 02/48172 (2002-06-01), None
patent: WO 02/079234 (2002-10-01), None
Berenguer, Marina, et al., “Hepatitis B and . . . ,” Proceedings of the Association of American Physicians, 110(2):98-112 (1998).
Dimasi, Nazzareno, et al., “Characterization of Engineered . . . ,” Journal of Virology 71(10):7461-7469 (Oct. 1997).
Elzouki, Abdul-Nasser, et al., “Serine protease inhibitors . . . ,” Journal of Hepatology 27:42-48 (1997).
Failla, Cristina Maria, et al., “Redesigning the substrate . . . ,” Folding & Design 1(1):35-42 (Jan. 10, 1996).
Han, Wei, et al., “Alpha-Ketoamides, Alpha-Ketoesters . . . ,” Bioorganic & Medicinal Chemistry Letters 10:711-713 (2000).
Hoofnagle, Jay H., et al., “The Treatment of Chronic Viral Hepatitis,” The New England Journal of Medicine 336(5):347-356 (Jan. 30, 1997).
Ingallinella, Paolo, et al, “Potent Peptide Inhibitors . . . ,” Biochemistry 37:8906-8914 (1998).
Kolykhalov, Alexander A., et al., “Specificity of the . . . ,” Journal of Virology 68(11):7525-7533 (Nov. 1994).
Komoda, Yasumasa, et al., “Substrate Requirements of . . . ,” Journal of Virology 68(11):7351-7357 (Nov. 1994).
Landro, James A., et al., “Mechanistic Role of . . . ,” Biochemistry 36:9340-9348 (1997).
Llinas-Brunet, Montse, et al., “Peptide-Based Inhibitors . . . ,” Bioorganic & Medicinal Chemistry Letters 8:1713-1718 (1998).
Marchetti, Antonella, et al., “Synthesis of Two . . . ,” Synlett S1:1000-1002 (1999).
Martin, F., et al., “Affinity selection of a . . . ,” Protein Engineering 10(5):607-614 (1997).
Martin, Franck, et al., “Design of Selective . . . ,” Biochemistry 37:11459-11468 (1998).
Orvieto, Federica, et al., “Novel, Potent Phenethylamide . . . ,” Bioorganic & Medicinal Chemistry Letters 13:2745-2748 (2003).
Pizzi, Elisabetta, et al., “Molecular model of . . . ,” Proc. Natl. Acad. Sci. USA 91:888-892 (Feb. 1994).
BioWorld Today, 9(217):4 (Nov. 10, 1998).
U.S. Appl. No. 10/052,386, filed Jan. 18, 2002.
Orvieto, Federica, et al., “Novel, Potent Phenethylamide Inhibitors . . . ”, Bioorganic & Medicinal Chemistry Letters, 13:2745-2748 (2003).
PCT International Search Report dated Jul. 19, 2005 for corresponding PCT Application No. PCT/US2004/027422.
Chen Kevin X.
Girijavallabhan Viyyoor M.
Njoroge F. George
Velazquez Francisco
Venkatraman Srikanth
Aulakh Charanjit S
Farquharson-Torres Serena
Kalyanaraman Palaiyur S.
Schering Corporation
LandOfFree
Peptidomimetic NS3-serine protease inhibitors of hepatitis C... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidomimetic NS3-serine protease inhibitors of hepatitis C..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidomimetic NS3-serine protease inhibitors of hepatitis C... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026089